Skip to content
  •   Site Login
  •   Site Login
HiFlow - COPD Study - myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home – a multi-center randomized controlled trial
  • Home
  • About HiFlo
    • Who Is Eligible
  • Study Locations
  • About COPD
  • About Clinical Trials
  • Home
  • About HiFlo
    • Who Is Eligible
  • Study Locations
  • About COPD
  • About Clinical Trials
Am I Eligible?

Mayo Clinic Rochester

  • 200 First St. SW
    Rochester, MN 55905
  • Principal Investigator:
    Megan Dulohery Scrodin
  • Study Coordinator:
    Brandon Clapp
  • 507-284-2122
  • Clapp.Brandon@Mayo.edu
HiFlow - COPD Study - myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home – a multi-center randomized controlled trial

HiFlo COPD Coordinating Site:

Temple University Hospital
3401 N. Broad Street
Philadelphia, PA 19140

Copyright © 2025 Temple University Hospital

TERMS OF USE

PRIVACY & NON-DISCRIMINATION NOTICES

WEB PRIVACY POLICY

Website by ImageBloom website design and marketing for clinical research industry